<https://rdf.molmedb.upol.cz/reference/ref2416> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00092>,
		<https://identifiers.org/molmedb/MM471709>,
		<https://rdf.molmedb.upol.cz/interaction/membrane19>,
		<https://identifiers.org/molmedb/MM00198>,
		<https://identifiers.org/molmedb/MM471710>;
	<http://purl.org/ontology/bibo/pmid> "28152427"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>;
	<http://purl.org/dc/terms/bibliographicCitation> "Elkamhawy A, Park JE, Hassan AHE, Ra H, Pae AN, Lee J, Park BG, Moon B, Park HM, Roh EJ.: Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction. Eur J Med Chem, Volume 128, 2017"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.ejmech.2016.12.057"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int983536> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2416> .
<https://rdf.molmedb.upol.cz/interaction/int980232> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2416> .
<https://rdf.molmedb.upol.cz/interaction/int983099> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2416> .
<https://rdf.molmedb.upol.cz/interaction/int983119> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2416> .